Subscribe to RSS
DOI: 10.1055/s-0038-1654101
Anticoagulant Properties of an Acid Mucopolysaccharide Preparation Isolated from Rat Kidney[*]
Publication History
Publication Date:
26 June 2018 (online)

Summary
The anticoagulant properties of an acid mucopolysaccharide preparation isolated from rat kidney were investigated. This preparation was characterized chemically in a previous work (1) and was found to contain heparin-like material.
A qualitative similarity in the behaviour of our preparation to that of heparin becomes apparent from the results obtained in a number of tests in which heparin was also tested. Quantitatively, this preparation possessed in the recalcification test about 8% of the potency of the standard heparin preparation. Some of its subfractions obtained from a fractionation on an Ecteola-cellulose column exhibited a higher activity.
This work supports previous findings on the chemical characterization of this preparation.
* This paper is part of a thesis submitted by Mr. D. Allalouf to the Hebrew University, Jerusalem, in partial fulfilment of the requirements for the Ph. D. degree.
-
References
- 1 Allalouf D, Ber A, Sharon N. Acid mucopolysaccharides in rat kidneys: Biochim. biophys. Acta (Amst.) 83: 278 1964;
- 2 Biggs R, MacFarlane R. G. Human blood coagulation and its disorders. Third Edit.. 384 Blackwell Scientific Publications; Oxford: 1962
- 3 Biggs R, MacFarlane R. G. Human blood coagulation and its disorders. Third Edit.. 390 Blackwell Scientific Publications; Oxford: 1962
- 4 Conley G. L, Hartman R. C, Bailey J. G. The relationship of heparin activity to platelet concentration. Proc. Soc. exp. Biol. (N. Y.) 69: 284 1948;
- 5 Godai H. C. The assay of heparin in thrombin systems. Scand. J. clin. Lab. Invest 13: 153 1961;
- 6 Grossman B. J, Astrup T. In vitro effects of heparin and chondroitin sulfuric acid B on the generation of thrombin. Scand. J. clin. Lab. Invest 13: 79 1961;
- 7 Grossman B. J, Dorfman A. In vitro comparison of the antithrombic action of heparin and chondroitin sulfuric acid-B. Pediatrics 20: 506 1957;
- 8 Jaques L. B, Bell H. J. Determination of heparin, in Methods of Biochemical analysis. Vol. 7 p. 253. Edit. D. Glick 1959.
- 9 Jorpes J. E. Heparin in the treatment of thrombosis. Second Edit.. 51 Geoffrey Cumberlege, Oxford University Press; London: 1946
- 10 Marx W, Marx L, Rucker P, Ruggeri L, Freeman L. Tissue heparin and mast cells in rats and rabbits. Proc. Soc. exp. Biol. (N. Y.) 94: 217 1957;
- 11 Monkhouse F. G, Mackneson R. G, Bambers G. Extractable heparin level in rat tissues under normal and experimental conditions. Proc. Soc. exp. Biol. (N. Y.) 95: 489 1957;
- 12 Nilsson I. M, Wenckert A. Demonstration of a heparin-like anticoagulant in normal blood. Acta med. scand. Supplem. 297 1954
- 13 Quick A. Hemorrhagic diseases. 431 Lea & Febiger; Philadelphia: 1957
- 14 Quick A. Hemorrhagic diseases. 379 Lea & Febiger; Philadelphia: 1957
- 15 Riley J. F. The Mast Cells. 86-88 E. & S. Livingstone Ltd.; Edinburgh and London: 1959
- 16 Sjölin K. E. The thrombin generation test in the diagnosis of classical hemophilia and Christmas disease. Scand. J. clin. Lab. Invest 8: 138 1956;